Effect of Roux-en-Y gastric bypass on pharmacologic dependence in obese patients with type 2 diabetes | Zendy

Alistair Sharples | Zendy; Michael Mullan | Zendy; Krista Hardy | Zendy; Ashley Vergis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Roux-en-Y gastric bypass on pharmacologic dependence in obese patients with type 2 diabetes

Author(s) -

Alistair Sharples,

Michael Mullan,

Krista Hardy,

Ashley Vergis

Publication year - 2019

Publication title -

canadian journal of surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.609

H-Index - 64

eISSN - 1488-2310

pISSN - 0008-428X

DOI - 10.1503/cjs.005018

Subject(s) - medicine , glycated hemoglobin , diabetes mellitus , roux en y anastomosis , weight loss , type 2 diabetes , gastric bypass , insulin , type 2 diabetes mellitus , obesity , surgery , endocrinology

More than half the diabetes-related health care costs in Canada relate to drug costs. We aimed to determine the effect of Roux-en-Y gastric bypass (RYGB) on the use of insulin and orally administered hypoglycemic medications in patients with diabetes. We also looked to determine overall cost savings with the procedure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research